内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Jacobson Mark L.. Director active across 1 company, notably Axsome Therapeutics, Inc.. In total, 18 disclosures have been logged. Split: 0 buy · 7 sells. Total volume traded: €9.5m. Activity tracked since 1 April 2024. The latest transaction was filed on 3 September 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Jacobson Mark L.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
10,000 股@ US$12.95Common StockSEC:0001193125-26-382277:0
10,000 股@ US$208.65Common StockSEC:0001193125-26-382277:1
4,517 股@ US$12.950.0005% mcap1.3% 占其流量Common StockSEC:0001193125-26-207148:0
4,517 股@ US$227.940.0095% mcap23.2% 占其流量Common StockSEC:0001193125-26-207148:1
233 股@ US$12.950.0000% mcap0.1% 占其流量Common StockSEC:0001193125-26-207148:2
233 股@ US$228.180.0005% mcap1.2% 占其流量Common StockSEC:0001193125-26-207148:3
35,378 股@ US$2.851.9% 占其流量Common StockSEC:0001193125-26-083586:0
10,000 股@ US$2.850.6% 占其流量Common StockSEC:0001193125-25-211788:0
5,783 股@ US$116.1912.9% 占其流量Common StockSEC:0001193125-25-206494:0
25,000 股@ US$110.4463.7% 占其流量Common StockSEC:0000950170-25-084556:1
25,000 股@ US$8.024.6% 占其流量Common StockSEC:0000950170-25-084556:0
20,673 股@ US$6.471.4% 占其流量Common StockSEC:0000950170-25-078552:0
20,673 股@ US$104.6622.6% 占其流量Common StockSEC:0000950170-25-078552:1
20,000 股@ US$6.471.4% 占其流量Common StockSEC:0000950170-25-078552:2
20,000 股@ US$103.4521.8% 占其流量Common StockSEC:0000950170-25-078552:3
47,739 股@ US$4.044.7% 占其流量Common StockSEC:0000950170-24-094967:0
13,693 股@ US$1.300.4% 占其流量Common StockSEC:0000950170-24-066177:0
24,662 股@ US$1.300.8% 占其流量Common StockSEC:0000950170-24-039617:0
About Jacobson Mark L.
Jacobson Mark L. is a declarant linked to Axsome Therapeutics, Inc., where the listed role is Chief Operating Officer. He has 16 filings in total, and across the sampled recent filings from 2024-04-01 to 2026-05-05, the activity is entirely sales, for a total of EUR 7658220, with Levée d'options as the most common transaction nature.